JuanPabloArnolettiMD(He/Him)
General Surgery • Orlando, FLHepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast)
Physician
Dr. Arnoletti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Orlando Health Cancer Institute
1414 Kuhl Ave
Orlando, FL 32806
Summary
- Dr. Juan Pablo Arnoletti is a surgical oncologist in Orlando, FL and is affiliated with Orlando Health Cancer Institute. He received his medical degree from Universidad de la República in Montevideo, Uruguay and has been in practice 25 years. He specializes in pancreas and hepato-biliary surgery for malignancy, soft tissue sarcoma, and surgical oncology and is experienced in complex gastrointestinal surgery and surgical treatment of all pancreatic diseases including pancreatic necrosis.
Education & Training
Drexel University College of Medicine/Hahnemann University HospitalResidency, Surgery, 1994 - 2000
Universidad de la República - Facultad de MedicinaClass of 1992
Certifications & Licensure
FL State Medical License 2012 - 2026
PA State Medical License 1995 - 2002- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 114 citationsPreoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma.Ching Wei D. Tzeng, John B. Fiveash, Richard A. Popple, J. Pablo Arnoletti, Suzanne Russo
Cancer. 2006-07-15 - 32 citationsT1R2 receptor-mediated glucose sensing in the upper intestine potentiates glucose absorption through activation of local regulatory pathwaysKathleen R. Smith, Elnaz Karimian Azari, Traci E. LaMoia, Tania Hussain, Veronika Vargova
Molecular Metabolism. 2018-11-01 - 29 citationsJQ1 Induces DNA Damage and Apoptosis, and Inhibits Tumor Growth in a Patient-Derived Xenograft Model of Cholangiocarcinoma.Patrick L. Garcia, Aubrey L. Miller, Tracy L. Gamblin, John D. Christein, J. Pablo Arnoletti
Molecular Cancer Therapeutics. 2018-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
